Aktis Oncology Initiates Second Phase 1b Clinical Trial for AKY-2519, a Miniprotein Radioconjugate Targeting B7-H3
Aktis Oncology Initiates Second Phase 1b Clinical Trial for AKY-2519, a Miniprotein Radioconjugate Targeting B7-H3 GlobeNewswire
1140 материалов по теме, собраны автоматически из проверенных источников
Aktis Oncology Initiates Second Phase 1b Clinical Trial for AKY-2519, a Miniprotein Radioconjugate Targeting B7-H3 GlobeNewswire
Roswell Park и Generate ввели препарат первому пациенту в исследовании рака яичников Investing.com
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial Of ‘Armored’ Car T Therapy For Ovarian Cancer TradingView
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer Roswell Park Comprehensive Cancer Center
The FDA has issued a final rule that would remove references to animal studies in its drug safety regulations, as part of a larger effort across HHS to reduce what it calls “unnecessary animal testing” in biomedical research. In addition to the new FDA rule, which would take effect Feb. 4, 2027, the NIH simultaneously…
The VIRAGE Trial Cracked the Pancreatic Cancer Wall. Now the Hard Question Is Whether the Field Can Read the Blueprint. The Clinical Trial Vanguard
Clinical Trials Aren’t Just a Last Resort in Cancer Care TheCitizen.com
First child with Down's syndrome in 'revolutionary' cancer trial BBC
First child with Down's syndrome in 'revolutionary' cancer trial BBC
A real-world study of 8,391 patients found that autonomous artificial intelligence (AI) could free up enough clinical capacity to provide more than 8,500 additional face-to-face dermatology appointments across two U.K. hospitals over 16 months.
A new study from the Institute for Health Metrics and Evaluation (IHME) finds that chewing tobacco use contributed to an estimated 251,000 deaths globally in 2023, with health loss overwhelmingly concentrated in South Asia.
National Cancer Institute Highlights Cancer Research Advances and Priorities for Accelerating Progress Oncodaily
A genetic vulnerability in clear cell renal cell carcinoma, the most aggressive type of kidney cancer, may lend itself to a combination treatment strategy that causes the cancer cells to self-destruct, according to recent research published in the Proceedings of the National Academy of Sciences.
AutoNation Establishes Children’s Cancer Research Fund at Sylvester with a $100,000 Grant South Florida Hospital News
For people living with HIV, the road to a promising cancer treatment can be longer than it should be, literally.